Parathyroid Hypofunction – Top USMLE Diseases

Parathyroid Hypofunction – Top USMLE Diseases

by Carlo Raj, MD, Michael Lazarus, MD

This course covers everything you need to know about Parathyroid Hypofunction.

Raise your test scores with the support of high quality videos today!

Course Details

  • Videos 3
  • Duration 0:10 h
  • Quiz questions 6
  • Concept Pages 2

Content

Your Educators of course Parathyroid Hypofunction – Top USMLE Diseases

 Carlo Raj, MD

Carlo Raj, MD

Dr. Carlo Raj is a Physician and Lecturer at Becker’s Healthcare, in Illinois, USA, and the CEO and founder of Indus Intellect Virtual MedEd, a medical education consulting company.
He obtained his MD from Medical University of the Americas (MUA) and is an international lecturer and public speaker.
Within Lecturio, Dr. Raj teaches courses on Pathology.

 Michael Lazarus, MD

Michael Lazarus, MD

Dr. Michael Lazarus is a Professor of Clinical Medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA).
He obtained his MD from the University of the Witwatersrand School of Health Sciences, South Africa, and trained at the Washington University School of Medicine. In 2003, he joined the faculty at UCLA and currently serves as the Medical Director of the UCLA Hospitalist Section.
He has won various teaching awards, such as the Serge & Yvette Dadone Clinical Teaching Award, and was featured in the Los Angeles Magazine's Top Doctors Guide in 2021.
Within Lecturio, Dr. Lazarus teaches courses on Endocrinology.


User reviews

(1)
2,0 of 5 stars
5 Stars
0
4 Stars
0
3 Stars
0
2 Stars
1
1  Star
0
 
Hungry bone syndrome explanation
By Abdul Q. on 01. July 2020 for Iatrogenic Hypoparathyroidism with Case

firstly the reasoning was very vague and not explained well with a quick physiology reference secondly hungry bone syndrome described as surgery for hypoparathyroidectomy . Hungry bone syndrome (HBS) refers to the rapid, profound, and prolonged hypocalcaemia associated with hypophosphataemia and hypomagnesaemia, and is exacerbated by suppressed parathyroid hormone (PTH) levels, which follows parathyroidectomy in patients with severe primary hyperparathyroidism (PHPT) and preoperative high bone turnover.